123 results
Page 5 of 7
6-K
EX-99.1
dxmwyevw8
6 Sep 19
Mesoblast Reports 2019 Full Year Results
6:35am
6-K
EX-99.2
reefyjuoa6o3sdd
6 Sep 19
Mesoblast Reports 2019 Full Year Results
6:35am
6-K
EX-99.1
drppg8oq6b7071xl0kc
30 Aug 19
Current report (foreign)
6:01am
6-K
EX-99.1
aqry4quzg1m
30 Jul 19
Circulation Research Special Article Highlights Potential of
12:00am
6-K
EX-99.2
aryfw1akoj0u9h7w
19 Jun 19
Mesoblast to Host Virtual Symposium with Key Opinion Leader Highlighting Acute Graft Versus Host Disease
6:02am
6-K
EX-99.1
1qbx ejrh03
12 Jun 19
Current report (foreign)
6:02am
6-K
EX-99.1
8wj0y 6f4d
3 Jun 19
Mesoblast Reports Financial Results and Operational Highlights
12:00am
6-K
EX-99.2
85dexr6xgp
3 Jun 19
Mesoblast Reports Financial Results and Operational Highlights
12:00am
6-K
cinj12mqakun fvtlc
3 Jun 19
Current report (foreign)
12:00am
6-K
EX-99.1
i5xtq 992f37s
21 May 19
Mesoblast to Present at 2019 RBC Capital Markets Global Healthcare Conference
12:00am
6-K
EX-99.1
tzokdjz0
26 Mar 19
Current report (foreign)
12:00am
6-K
EX-99.1
dyp tha2asdafsd
14 Mar 19
Mesoblast Features at Upcoming U.s. Investor Conferences
5:22pm
6-K
EX-99.2
sz3c2s8f9jhatlv95
22 Feb 19
Mesoblast Reports Financial Results and Operational Highlights
12:00am
6-K
i1rjhomltrjoa5k0pn
22 Feb 19
Current report (foreign)
12:00am
6-K
EX-99.2
jckv4h25jholzvy 97
5 Dec 18
Chairman’s Address to the Mesoblast 2018 Annual General Meeting
12:00am
6-K
EX-99.2
2blvb
21 Nov 18
Current report (foreign)
12:00am
6-K
EX-99.1
bnl6ak 9ssrrw5m9a
16 Nov 18
Clinically Meaningful Outcome In Nih Trial of MPC-150-IM for Heart Failure Lvad Recipients Provides Pathway for Potential Regulatory Approval
12:00am
6-K
EX-99.2
bwgkq w1fk
16 Nov 18
Clinically Meaningful Outcome In Nih Trial of MPC-150-IM for Heart Failure Lvad Recipients Provides Pathway for Potential Regulatory Approval
12:00am
6-K
e3qf0
15 Nov 18
Q1.FY19-30SEP2018
9:17pm
6-K
EX-99.3
06wiza7yz44dcu6
7 Nov 18
Quarterly report for entities subject to Listing Rule 4.7B
6:06am